Home / GHRP-2 5MG 10MG 12MG 15MG
  • GHRP-2 5MG 10MG 12MG 15MG
  • GHRP-2 5MG 10MG 12MG 15MG
  • GHRP-2 5MG 10MG 12MG 15MG

GHRP-2 5MG 10MG 12MG 15MG

The peptide will be provided as lyophilized powder to ensure maximum stability.
GHRP-2 is a synthetic growth hormone-releasing peptide composed of six amino acids. It stimulates growth hormone (GH) secretion by activating the growth hormone-releasing receptor. GHRP-2 also increases appetite and promotes food intake. In the medical field, GHRP-2 is used to treat growth hormone deficiency and study appetite regulation mechanisms. It is also employed to promote muscle growth and fat diabetes.
$70
$88
Quantity
ADD TO CART
BUY IT NOW
  • Detail

    GHRP-2 (Pralmorelin) 5mg

    The Most Potent Classic GHRP  |  Ghrelin-Receptor GH Secretagogue Hexapeptide

    D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH₂ · KP-102 · Research Use Only

    📈 Peak-GH Champion

    Regarded as the most potent member of the traditional GHRP family by peak growth-hormone release in published comparative studies.

    🏛 Clinical Heritage

    As pralmorelin (KP-102), GHRP-2 is the only GHRP with clinical approval history — authorized in Japan as a diagnostic GH-stimulation agent.

    🧬 Ghrelin Mimicry

    A potent GHS-R1a agonist that mimics endogenous ghrelin signaling — GH release plus appetite-pathway engagement.

    🧊 D-Amino-Acid Stability

    D-residues at positions 1, 2 and 5 confer strong resistance to proteolytic degradation in research models.

    Product Overview

    GHRP-2 (Growth Hormone Releasing Peptide-2), also known by its INN name pralmorelin and developmental code KP-102, is a synthetic hexapeptide with the sequence D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH₂. It belongs to the GHRP family — non-natural peptides with no structural homology to GHRH that potently stimulate somatotrope GH secretion via the ghrelin / growth-hormone-secretagogue receptor (GHS-R1a).

    Among the traditional GHRPs, GHRP-2 is consistently described as the most potent by peak GH release, and it holds a unique position in the family: as pralmorelin it is the only GHRP to have achieved clinical approval, authorized in Japan as a diagnostic agent for growth-hormone stimulation testing. Pharmacological characterization (Doi et al., 2004) showed KP-102's GH-releasing potency equivalent to or exceeding other secretagogues, with robust effects in both animal and human studies.

    Each vial contains 5mg of high-purity GHRP-2 as a white to off-white lyophilized powder, supplied strictly for in-vitro and laboratory research use only. 

    Specifications

    Product Name GHRP-2 (Pralmorelin)
    Synonyms KP-102 · (Des-His¹, D-Ala¹, D-2-Nal²)-GHRP-6 analog · CHRP-2 · Pralmorelin
    CAS Number 158861-67-7
    Amino Acid Sequence D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH₂ (6 residues, C-terminally amidated; 2-Nal = 2-naphthylalanine)
    Molecular Formula C45H55N9O6 (free base) 
    Molecular Weight ≈ 818.0 g/mol (free base; ≈ 873 as TFA salt) 
    Net Content 5 mg / vial 
    Appearance White to off-white lyophilized powder
    Purity ≥ 98% (by HPLC) 
    Solubility Soluble in water / aqueous buffer
    Storage Store lyophilized at -20°C, protected from light and moisture; refrigerate after reconstitution and use promptly 

    Structure: From GHRP-6 to GHRP-2

    🧪  The design logic — GHRP-2 was developed by systematic modification of the GHRP-6 scaffold (His-D-Trp-Ala-Trp-D-Phe-Lys-NH₂). The N-terminal histidine was removed, position 1 was given a D-alanine, and the D-tryptophan at position 2 was replaced with D-2-naphthylalanine (D-2-Nal) — a bulkier aromatic that strengthens receptor engagement.

    🛡  Built-in protease resistance — the D-amino acids at positions 1, 2 and 5 make the peptide largely invisible to proteases that evolved to cleave L-configured bonds, extending functional stability in research models.

    📊  The potency outcome — these changes produced what comparative studies describe as the strongest peak-GH response in the traditional GHRP family, establishing GHRP-2 as the reference potency compound of the class.

    Mechanism of Action

    Step What Happens
    1. GHS-R1a Binding GHRP-2 binds the ghrelin / growth-hormone-secretagogue receptor 1a (GHS-R1a) at both pituitary and hypothalamic levels — the same receptor engaged by endogenous ghrelin.
    2. Potent GH Release Somatotrophs release GH in robust pulses; GHRP-2 acts synergistically with GHRH, producing GH responses exceeding either stimulus alone.
    3. HPA & Prolactin Co-Stimulation Unlike selective agonists, GHRP-2 activates the hypothalamo-pituitary-adrenal axis: published studies document cortisol/ACTH and prolactin elevation, particularly at higher doses — a defining pharmacological feature of first-generation GHRPs.
    4. Appetite-Pathway Engagement As a ghrelin mimetic, GHRP-2 stimulates food intake in animal models — central administration stimulates eating even without proportional GH responses, making it a standard tool in appetite-circuit research.

    GHRP-2 vs GHRP-6 vs Ipamorelin

    Aspect GHRP-2 (this product) GHRP-6 Ipamorelin
    Peak GH Potency Strongest of the traditional family High (first-in-human GHRP) Equipotent range, partial agonist
    Cortisol / ACTH Elevated at higher doses Elevated No significant elevation
    Prolactin Elevated at higher doses Elevated No significant elevation
    Appetite Stimulation Strong Strongest in the family Markedly weaker
    Research Position Potency reference; clinically approved lineage (pralmorelin, Japan) First-generation; appetite-research tool Selectivity benchmark (see our ipamorelin listing)

    Research Highlights

    📖 Doi et al., 2004 — KP-102 Pharmacology

    Pharmacological characteristics of KP-102 (GHRP-2) characterized it as a potent synthetic GH secretagogue with GH-releasing potency equivalent to the leading compounds of its class.

    📖 Roh et al., 2002 — Family Potency Ranking

    "To date, GHRP-2 seems to be the most potent member of the family of GHRPs" — establishing its benchmark position in comparative GH-secretion studies.

    📖 Laferrère et al., 2005 (PMC2824650)

    GHRP-2, like ghrelin, enhances appetite in human studies — documenting the ghrelin-mimetic feeding effect alongside GH release.

    🏛 Pralmorelin Diagnostic Approval (Japan)

    GHRP-2 is the only GHRP with clinical approval history: pralmorelin is authorized in Japan as a diagnostic agent for growth-hormone stimulation testing — a regulatory precedent unique in this peptide family.

    Research Applications & Compliance Notes

    🧬  Growth-axis pharmacology — GHS-R1a agonism, GH-secretion kinetics, and GHRH-synergy designs.
    🍽  Appetite-circuit research — ghrelin-mimetic feeding studies (central and peripheral administration models).
    🎯  Selectivity comparisons — HPA-axis and prolactin co-stimulation versus ipamorelin-class agonists.
    🧪  GHRP structure-activity studies — D-2-Nal scaffold modifications and receptor-engagement assays.

    Compliance note: GHRP-2 (pralmorelin) is listed under peptide hormones / growth factors on the WADA Prohibited List (category S2), and its misuse in sport is an established detection target with published urinary screening methods. Buyers conducting sports-related research should factor this in.

    Reconstitution & Handling

    💧  Add sterile or bacteriostatic water slowly down the side of the vial; swirl gently until fully dissolved — do not shake vigorously.
    🧪  Aliquot reconstituted solution to avoid repeated freeze-thaw cycles; label each aliquot with batch, concentration and preparation date.
    🧊  Lyophilized powder: store frozen (-20°C), protected from light and moisture; reconstituted solution: refrigerate and use within your validated stability window. 
    ⚖️  Handle with aseptic technique and appropriate PPE per your laboratory SOP.

    Quality Assurance

    ✔  Lot-specific Certificate of Analysis: HPLC purity confirmation + mass-spectrometry identity verification (expected intact mass ≈ 818 Da for the free-base hexapeptide; confirm salt form per your batch documentation).

    ✔  Third-party batch testing documentation available upon request.

    References & Further Reading

    1. Doi N, et al. Pharmacological characteristics of KP-102 (GHRP-2), a novel synthetic growth hormone secretagogue. 2004. (Cited 19+)
    2. Roh SG, et al. Characterization of growth hormone secretion in response to GHRPs. Asian-Australas J Anim Sci. 2002. (GHRP family potency ranking)
    3. Laferrère B, et al. Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, enhances appetite… PMC2824650. 2005.
    4. GHRP-2 — ChemicalBook CB1104514 (CAS 158861-67-7, C₄₅H₅₅N₉O₆, FW 817.97; synonyms incl. pralmorelin, KP-102).
    5. Optoelectronical screening methods for pralmorelin and its metabolite in urine — doping-control detection literature. SPIE Proc. 2018.
    Disclaimer: This product is intended exclusively for in-vitro laboratory research use. It is not approved for human or animal use, is not a drug, food, cosmetic, or dietary supplement, and is not intended to diagnose, treat, cure or prevent any disease. All products are supplied strictly for research purposes only.
  • Customer Reviews
    No comments